This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dsm IP Assets B.v.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Inventor Spotlight: Cindy Gerhardt
Introduction
Cindy Gerhardt, an innovative inventor based in Basel, Switzerland, has made significant contributions to the field of biochemistry. Her research focuses on the development of peptides that can potentially influence dietary habits during stress, showcasing her commitment to addressing real-world problems through scientific innovation.
Latest Patents
Cindy holds a notable patent for her invention, titled "Peptides containing tryptophan." This patent involves a composition comprising a tryptophan-containing peptide that possesses a Trp/LNAA ratio of more than 0.1, aimed at decreasing eating or appetite during or after periods of stress. This inventive approach highlights the intersection of nutrition and mental well-being, emphasizing the potential impact of dietary choices on human health.
Career Highlights
Cindy Gerhardt's career is marked by her role at DSM IP Assets B.V., where she applies her expertise in biochemical research to develop innovative solutions. Her patent serves as a testament to her dedication and skill in the field, setting her apart as a pioneer in peptide research.
Collaborations
Throughout her career, Cindy has collaborated with esteemed colleagues, including Joris Kloek and Rob Markus. These partnerships reflect a collaborative spirit that fosters innovation and enhances research outcomes within her field.
Conclusion
Cindy Gerhardt stands out as an exemplary inventor whose work with peptides offers promising avenues for addressing appetite control during stressful times. Her patent not only showcases her ingenuity but also contributes to the broader conversation about the relationship between stress, diet, and health. As she continues her work at DSM IP Assets B.V., Cindy’s contributions are likely to pave the way for future breakthroughs in the realm of biochemistry.